Last updated 2026-06-18
- Raised $9M funding round led by New Age Ventures, Oct 2022
- Raised $540k funding round, May 2024
- Raised $2.7M funding round, Dec 2020
Total raised
$16.9M
Last: 2024-05
Stage
Series B
Founded
2012
Headcount
17
HQ
Modi'in-Maccabim-Re'ut, Israel
Sector
Health Tech & Life Sciences
About
FEMSelect is the developer of EnPlace, a minimally invasive and mesh-free system for pelvic floor ligament fixation. The EnPlace procedure takes approximately 30 minutes. Its patented delivery system enables precise guidance, insertion, and deployment of the anchor unit, which is designed to be introduced through the vaginal wall and secured to the pelvic floor ligament to provide stabilization. EnPlace is FDA cleared and CE marked. The device is a combination of a Nitinol-based anchor, surgical sutures, and an innovative attachment method, and the surgery is conducted with no deep dissection or mesh. EnPlace has been tested in a human trial in Israel and is protected by global and U.S. patents.
Funding history · 7 rounds · $16.9M total
2024-05
$540K
2022-10
2020-12
2019-12
2017-05
$3.0M
2012-12
Undisclosed
2012-01
Grant
$750K
Q&A
- What is FEMSelect's primary product?
- FEMSelect is the developer of EnPlace, a minimally invasive and mesh-free system designed for pelvic floor ligament fixation.
- When was FEMSelect founded?
- FEMSelect was founded in October 2012.
- How many employees does FEMSelect currently have?
- FEMSelect has 11-50 employees.
- What is the total amount of funding FEMSelect has raised to date?
- FEMSelect has raised a total of $16,890,000 USD.
- When was FEMSelect's most recent funding round and who participated?
- FEMSelect's most recent funding round occurred in May 2024, with participation from Robin Hood Ventures.
- Which investors participated in FEMSelect's October 2022 funding round?
- In October 2022, FEMSelect received funding from New Age Ventures and Robin Hood Ventures.
- What is the regulatory status of FEMSelect's EnPlace device?
- The EnPlace device is FDA cleared and CE marked.
- Where are FEMSelect's headquarters located?
- FEMSelect's headquarters are located in Modi'in-Maccabim-Re'ut, Israel.
Team · 2
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
ConsumersDemographics & FamilyWomenHealthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
medical-devicesgynecologyminimally-invasivemedical-technologieswomen-healthdoctorssurgeonshospitalstreatmentsfemtech
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | femselect.com |
|---|---|
| linkedin.com/company/28632694 | |
| facebook.com/FEMSelect | |
| YouTube | youtube.com/channel/UCUXuID-G3yt22gTkPV8Ovuw |
Identifiers & details
| Former names | ProAcccess, Pop Medical Solutions |
|---|---|
| Founded | 2012-10 |
| Employees (exact) | 17 |
| Offices | Newark |
Radar intelligence
Patents
| EPO | 5 |
|---|
Web history (Wayback)
| Domain | femselect.com |
|---|
Certificate / subdomain footprint
| Subdomains | 9 |
|---|